Zimbabwe has declined a significant US health deal valued at $367m (272 million pounds) over five years because of the United States' demand for confidential biological samples.
This move was revealed following a official document dated December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesperson has since clarified that the United States was requesting health data for scientific study and commercial purposes while was unwilling to share the benefits from any future vaccines.
"We must now begin the challenging and unfortunate task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more dialogue to reach a agreement agreeable to all parties so the nation's vital HIV treatment initiative can continue.
Wider Context
This development follows a similar situation in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were filed about the security of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost openness and responsibility.
As per statements, Sixteen African countries have so far signed similar agreements, constituting over $18.3bn in committed funds.
Details of the Declined Deal
The funds for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation could have provided immense advantages for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"In essence, our country would provide the raw materials for scientific discovery without any assurance that the end products would be available to our people should a new pandemic emerge."
Sovereignty and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral deals were disrupting structures previously set up via the global organization.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This system is intended to guarantee that when a country contributes its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We are open to further dialogue with our American counterparts on how subsequent collaboration could be arranged in a manner that honours the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but suggested that negotiations need to persist given that much of the country's Aids initiatives were funded by foreign aid.
"In cases where technical issues arise, such as those involving data governance or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it said.
This impasse emphasises the ongoing tensions between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.